These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18402906)

  • 21. Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients.
    Fuji T; Fujita S; Ochi T
    Int Orthop; 2008 Aug; 32(4):443-51. PubMed ID: 17468868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Muehlhofer E; Dierig C; Misselwitz F; Kälebo P;
    Circulation; 2006 Nov; 114(22):2374-81. PubMed ID: 17116766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thromboprophylaxis with dabigatran after total hip arthroplasty in Indian patients: A subanalysis of a double-blind, double-dummy, randomized RE-NOVATE II study.
    Malhotra R; Babhulkar S; Sanjib KB; Clemens A; Dadi A; Iyer R; Kamath S; Mody B; Mutha S; Reddy G; Shah V; Shah V; Shetty N; Tapasvi S; Wadhwa M
    Asian J Surg; 2017 Apr; 40(2):145-151. PubMed ID: 27143213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
    Eriksson BI; Borris LC; Dahl OE; Haas S; Huisman MV; Kakkar AK; Misselwitz F; Muehlhofer E; Kälebo P
    Thromb Res; 2007; 120(5):685-93. PubMed ID: 17292948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study.
    Mismetti P; Samama CM; Rosencher N; Vielpeau C; Nguyen P; Deygas B; Presles E; Laporte S;
    Thromb Haemost; 2012 Jun; 107(6):1151-60. PubMed ID: 22476471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
    Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
    Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery.
    Sasaki S; Miyakoshi N; Matsuura H; Saito H; Nakanishi T; Kudo Y; Fujiya T; Shimada Y
    J Orthop Sci; 2011 Jan; 16(1):64-70. PubMed ID: 21293896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
    Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
    Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Venous thromboembolism prophylaxis after total hip arthroplasty].
    Kučera T; Malý R; Urban K; Sponer P
    Acta Chir Orthop Traumatol Cech; 2011; 78(2):101-5. PubMed ID: 21575551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement.
    Eriksson BI; Agnelli G; Cohen AT; Dahl OE; Mouret P; Rosencher N; Eskilson C; Nylander I; Frison L; Ogren M;
    Thromb Haemost; 2003 Feb; 89(2):288-96. PubMed ID: 12574809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
    Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
    Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The study of the thrombin generation mechanism and the effect of low molecular weight heparin as thromboprophylaxis in patients undergoing total knee and hip replacement.
    Gionis MN; Ioannou CV; Katsamouris AN; Katonis P; Balalis K; Sfyridaki K; Elalamy I; Gerotziafas GT
    Thromb Res; 2013; 132(6):685-91. PubMed ID: 24182549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
    Kakkar AK; Brenner B; Dahl OE; Eriksson BI; Mouret P; Muntz J; Soglian AG; Pap AF; Misselwitz F; Haas S;
    Lancet; 2008 Jul; 372(9632):31-9. PubMed ID: 18582928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two low-molecular-weight heparins for the prevention of postoperative venous thromboembolism after elective hip surgery. Reviparin Study Group.
    Planès A; Vochelle N; Fagola M; Bellaud M
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):499-505. PubMed ID: 9819000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
    Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
    Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.